Hoyle Cohen, LLC Abb Vie Inc. Transaction History

Hoyle Cohen, LLC

$1.31 Billion
Q2 2024

A detailed history of Hoyle Cohen, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hoyle Cohen, LLC holds 66,373 shares of ABBV stock, worth $14 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

66,373

Previous 69,782 4.89%

Holding current value

$14 Million

Previous $12.7 Million 10.41%

% of portfolio

0.87%

Previous 0.98%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $527,679 - $616,210	-3,409 Reduced 4.89%	66,373 $11.4 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $384,686 - $438,314	-2,407 Reduced 3.33%	69,782 $12.7 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $145,168 - $163,493	1,055 Added 1.48%	72,189 $11.2 Million
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $90,574 - $104,852	678 Added 0.96%	71,134 $10.6 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $93,552 - $116,419	-706 Reduced 0.99%	70,456 $9.49 Million
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $168,326 - $193,852	-1,164 Reduced 1.61%	71,162 $11.3 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.88 Million - $2.26 Million	-13,618 Reduced 15.85%	72,326 $11.7 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $166,554 - $191,027	-1,241 Reduced 1.42%	85,944 $11.5 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $35,505 - $45,139	-258 Reduced 0.3%	87,185 $13.4 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $80,639 - $100,051	-611 Reduced 0.69%	87,443 $14.2 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $26,642 - $33,710	-248 Reduced 0.28%	88,054 $11.9 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $58,413 - $66,308	-549 Reduced 0.62%	88,302 $9.53 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $20,936 - $23,324	-199 Reduced 0.22%	88,851 $10 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $11,457 - $12,613	112 Added 0.13%	89,050 $9.64 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $3.87 Million - $5.23 Million	48,114 Added 117.86%	88,938 $9.53 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $66,923 - $78,546	779 Added 1.95%	40,824 $3.58 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $127,883 - $171,127	1,743 Added 4.55%	40,045 $3.93 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $146,737 - $222,472	2,275 Added 6.31%	38,302 $2.92 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $115,335 - $144,309	-1,599 Reduced 4.25%	36,027 $3.19 Million
Q3 2019 Nov 15, 2019	SELL	$62.98 - $75.72 $16,626 - $19,990	-264 Reduced 0.7%	37,626 $2.85 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $209,320 - $267,560	-3,186 Reduced 7.76%	37,890 $2.76 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $372,971 - $438,969	-4,835 Reduced 10.53%	41,076 $3.31 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $47,799 - $58,950	-614 Reduced 1.32%	45,911 $4.23 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $49,256 - $54,757	-554 Reduced 1.18%	46,525 $4.4 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $76,223 - $90,189	-849 Reduced 1.77%	47,079 $4.36 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $43,520 - $58,278	-473 Reduced 0.98%	47,928 $4.54 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $4.33 Million - $4.75 Million	48,401	48,401 $4.68 Million

Others Institutions Holding ABBV

# of Institutions

4,100

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $374B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.

Account